Cargando…
“Heart failure in COVID-19 patients: Critical care experience”: A letter to the editor
Coronavirus disease 2019 (COVID-19) is associated with poor cardiovascular outcomes in patients with heart failure (HF) of all categories of ejection fraction (EF), but mainly in patients with HF with reduced EF. Moreover, cardiac transplant patients exhibit worse cardiovascular prognosis, high mort...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372782/ https://www.ncbi.nlm.nih.gov/pubmed/36159614 http://dx.doi.org/10.5501/wjv.v11.i4.216 |
_version_ | 1784767460867571712 |
---|---|
author | Tsigkou, Vasiliki Siasos, Gerasimos Oikonomou, Evangelos Bletsa, Evanthia Vavuranakis, Manolis Tousoulis, Dimitris |
author_facet | Tsigkou, Vasiliki Siasos, Gerasimos Oikonomou, Evangelos Bletsa, Evanthia Vavuranakis, Manolis Tousoulis, Dimitris |
author_sort | Tsigkou, Vasiliki |
collection | PubMed |
description | Coronavirus disease 2019 (COVID-19) is associated with poor cardiovascular outcomes in patients with heart failure (HF) of all categories of ejection fraction (EF), but mainly in patients with HF with reduced EF. Moreover, cardiac transplant patients exhibit worse cardiovascular prognosis, high mortality, and more admissions to the intensive care unit. In general, COVID-19 seems to de-teriorate the clinical status of HF and favors the development of acute respiratory distress syndrome and multiorgan failure, especially in the presence of cardiovascular comorbidities such as diabetes mellitus, kidney dysfunction, and older age. COVID-19 may induce new-onset HF with complex mechanisms that involve myocardial injury. Indeed, myocardial injury comprises a large category of detrimental effects for the myocardium, such as myocardial infarction type 1 or type 2, Takotsubo cardiomyopathy, microvascular dysfunction and myocarditis, which are not easily distinguished by HF. The pathophysiologic mechanisms mainly involve direct myocardial damage by severe acute respiratory syndrome coronavirus 2, cytokine storm, hypercoagulation, inflammation, and endothelial dysfunction. The proper management of patients with COVID-19 involves careful patient evaluation and ongoing monitoring for complications such as HF. |
format | Online Article Text |
id | pubmed-9372782 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-93727822022-09-23 “Heart failure in COVID-19 patients: Critical care experience”: A letter to the editor Tsigkou, Vasiliki Siasos, Gerasimos Oikonomou, Evangelos Bletsa, Evanthia Vavuranakis, Manolis Tousoulis, Dimitris World J Virol Letter to the Editor Coronavirus disease 2019 (COVID-19) is associated with poor cardiovascular outcomes in patients with heart failure (HF) of all categories of ejection fraction (EF), but mainly in patients with HF with reduced EF. Moreover, cardiac transplant patients exhibit worse cardiovascular prognosis, high mortality, and more admissions to the intensive care unit. In general, COVID-19 seems to de-teriorate the clinical status of HF and favors the development of acute respiratory distress syndrome and multiorgan failure, especially in the presence of cardiovascular comorbidities such as diabetes mellitus, kidney dysfunction, and older age. COVID-19 may induce new-onset HF with complex mechanisms that involve myocardial injury. Indeed, myocardial injury comprises a large category of detrimental effects for the myocardium, such as myocardial infarction type 1 or type 2, Takotsubo cardiomyopathy, microvascular dysfunction and myocarditis, which are not easily distinguished by HF. The pathophysiologic mechanisms mainly involve direct myocardial damage by severe acute respiratory syndrome coronavirus 2, cytokine storm, hypercoagulation, inflammation, and endothelial dysfunction. The proper management of patients with COVID-19 involves careful patient evaluation and ongoing monitoring for complications such as HF. Baishideng Publishing Group Inc 2022-07-25 2022-07-25 /pmc/articles/PMC9372782/ /pubmed/36159614 http://dx.doi.org/10.5501/wjv.v11.i4.216 Text en ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Letter to the Editor Tsigkou, Vasiliki Siasos, Gerasimos Oikonomou, Evangelos Bletsa, Evanthia Vavuranakis, Manolis Tousoulis, Dimitris “Heart failure in COVID-19 patients: Critical care experience”: A letter to the editor |
title | “Heart failure in COVID-19 patients: Critical care experience”: A letter to the editor |
title_full | “Heart failure in COVID-19 patients: Critical care experience”: A letter to the editor |
title_fullStr | “Heart failure in COVID-19 patients: Critical care experience”: A letter to the editor |
title_full_unstemmed | “Heart failure in COVID-19 patients: Critical care experience”: A letter to the editor |
title_short | “Heart failure in COVID-19 patients: Critical care experience”: A letter to the editor |
title_sort | “heart failure in covid-19 patients: critical care experience”: a letter to the editor |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372782/ https://www.ncbi.nlm.nih.gov/pubmed/36159614 http://dx.doi.org/10.5501/wjv.v11.i4.216 |
work_keys_str_mv | AT tsigkouvasiliki heartfailureincovid19patientscriticalcareexperiencealettertotheeditor AT siasosgerasimos heartfailureincovid19patientscriticalcareexperiencealettertotheeditor AT oikonomouevangelos heartfailureincovid19patientscriticalcareexperiencealettertotheeditor AT bletsaevanthia heartfailureincovid19patientscriticalcareexperiencealettertotheeditor AT vavuranakismanolis heartfailureincovid19patientscriticalcareexperiencealettertotheeditor AT tousoulisdimitris heartfailureincovid19patientscriticalcareexperiencealettertotheeditor |